Long-acting delivery and therapies for neovascular age-related macular degeneration
{{output}}
Introduction: Neovascular age-related macular degeneration (nAMD) represents a leading cause of severe visual impairment in individuals over 50 years of age in developed nations. Intravitreal anti-vascular endothelial growth fact... ...